| |
original article |
Date |
Title |
Authors Max. 6 Authors |
| 1 |
[GO] |
2025―Jun―19 |
Patients’ and families’ virtual care experiences for hypercholesterolemia management during the COVID-19 pandemic |
Nita Chahal, Arnelle Lardizabal, Janet Rush, Christian Delayun, Rayan Rahman, Rita Nobile, Brian W. McCrindle |
| 2 |
[GO] |
2025―May―29 |
Clinical outcomes of COVID-19 among patients with pure hypertriglyceridemia: A large-scale retrospective cohort study |
Godbless Ajenaghughrure, Ikponmwosa Ogieuhi, Oluwatoyosi Awotorebo, Zeth Tolu-Akinnawo, Aseed Mestahiri, Karldon Nwaezeapu, Anuoluwa Oyetoran, Kayode Ogunniyi |
| 3 |
[GO] |
2025―Mar―22 |
Prevention of Acute Systemic Reaction During LDL apheresis post COVID-19 by Icatibant Pre-Treatment |
Lauren R. Davidson, Naz Baecher, Brian Cheung, Theresa A. Bingemann, Robert C. Block |
| 4 |
[GO] |
2023―Aug―24 |
Effect of Dexamethasone on Modulating Lp(a) Levels in COVID-19 Pneumonia |
Laura Grace Kukuc, Matan Khanian, Robert Fishberg, Tiffany Haynes |
| 5 |
[GO] |
2023―Feb―08 |
SARS-CoV-2 infection-related deregulation of blood lipids in a patient with -/-LDLR familial homozygous hypercholesterolemia: a case report |
Dimitrios Bampatsias, Maria-Angeliki Dimopoulou, Dimitrios Karagiannakis, Alexandros Sianis, Eleni Korompoki, Kanella Kantreva, Erasmia Psimenou, Georgia Trakada, George Papatheodoridis, Kimon Stamatelopoulos |
| 6 |
[GO] |
2022―Nov―08 |
From the editor: Lipidology resurgent as the pandemic wanes |
John R. Guyton |
| 7 |
[GO] |
2022―Nov―06 |
Serum 25-hydroxycholesterol levels are increased in patients with coronavirus disease 2019 |
Takumi Asano, Tetsuji Wakabayashi, Yasuyuki Kondo, Kenta Okada, Daisuke Yamamuro, Yukiko Koga, Kiyonori Oka, Momoe Sakurai, Nagisa Sawayama, Manabu Takahashi, Hiroaki Okazaki, Ken Ebihara, Kensuke Minami, Yuji Morisawa, Shuji Hatakeyama, Masami Matsumura, Shun Ishibashi |
| 8 |
[GO] |
2022―Aug―10 |
Intracoronary Thrombus in a Patient with Elevated Lp(a) Levels and COVID-19 |
Tatiana Echeverry, Robert Fishberg, Laura Kukuc |
| 9 |
[GO] |
2022―Jun―25 |
Impact of the COVID-19 Pandemic on Cardiometabolic Health Parameters in Children with Preexisting Dyslipidemia |
Juliette Schefelker, Xiao Zhang, Ann Dodge, Kristen Marten, Greigory Dimailig, Heather L. Bartlett, Amy L. Peterson |
| 10 |
[GO] |
2022―Mar―29 |
Case Study of Hypertriglyceridemia from COVID-19 Pfizer-BioNTech Vaccination in a Patient with Familial Hypercholesteremia |
Brian Cheung, Jay Hwang, Ania Stolarczyk, Elliot Mahlof, Robert Block |
| 11 |
[GO] |
2022―Feb―12 |
Opportunities for preventing further endothelial dysfunction in pregnant COVID-19 patients with familial hypercholesterolemia |
Alpo Vuorio, Petri T. Kovanen, Frederick Raal |
| 12 |
[GO] |
2021―Dec―14 |
Lipid Biomarkers Associated with Mortality in COVID-19 |
Karolyn Teufel, Shant Ayanian, Tim Shields, Mohammad Shirazi, Michael Porter, Matthew Petersen, Sabyasachi Sen |
| 13 |
[GO] |
2021―Oct―31 |
HDL proteome remodeling associates with COVID-19 severity |
Douglas Ricardo de Souza Junior, Amanda Ribeiro Martins da Silva, Livia Rosa-Fernandes, Lorenna Rocha Reis, Gabrielly Alexandria, Santhosh D. Bhosale, Fabio de Rose Ghilardi, Talia Falcão Dalçóquio, Adriadne Justi Bertolin, José Carlos Nicolau, Claudio R.F. Marinho, Carsten Wrenger, Martin R. Larsen, Rinaldo Focaccia Siciliano, Paolo Di Mascio, Giuseppe Palmisano, Graziella Eliza Ronsein |
| 14 |
[GO] |
2021―Aug―10 |
Hypertriglyceridemia during hospitalization independently associates with mortality in patients with COVID-19 |
Wen Dai, Hayley Lund, Yiliang Chen, Jue Zhang, Kristen Osinski, Stephanie Zellner Jones, Lisa Baumann Kreuziger, José A. López, Ivor J. Benjamin, Roy L. Silverstein, Ze Zheng |
| 15 |
[GO] |
2021―Jun―04 |
Why continued lipoprotein apheresis is vital for homozygous familial hypercholesterolemia patients with COVID-19 |
Alpo Vuorio, Frederick Raal, Reinhard Klingel, Petri T. Kovanen |
| 16 |
[GO] |
2021―Jun―04 |
Collateral damage of the COVID-19 pandemic on the management of homozygous familial hypercholesterolemia |
Meral Kayikcioglu, Lale Tokgozoglu, Ozlem Kuman Tuncel, Sebnem Pirildar, Levent Can |
| 17 |
[GO] |
2021―Apr―21 |
Statins in COVID-19 infection: A rehash of old themes or truly a new hope? |
Xiaoming Jia, Salim S. Virani |
| 18 |
[GO] |
2021―Mar―07 |
Association between antecedent statin use and severe disease outcomes in COVID-19: a retrospective study with propensity score matching |
Prateek Lohia, Shweta Kapur, Sindhuri Benjaram, Tanveer Mir |
| 19 |
[GO] |
2020―Dec―29 |
Impact of prior statin use on clinical outcomes in COVID-19 patients: data from tertiary referral hospitals during COVID-19 pandemic in Italy |
Gianfranco Mitacchione, Marco Schiavone, Antonio Curnis, Marcello Arca, Spinello Antinori, Alessio Gasperetti, Giosuè Mascioli, Paolo Severino, Federica Sabato, Maria M. Caracciolo, Gianmarco Arabia, Laura D'Erasmo, Maurizio Viecca, Massimo Mancone, Massimo Galli, Giovanni B. Forleo |
| 20 |
[GO] |
2020―Sep―15 |
Negative impact of COVID-19 pandemic on the lifestyle and management of patients with Homozygous Familial Hypercholesterolemia |
Meral Kayikcioglu, Lale Tokgozoglu, Ozlem Kuman Tuncel, Sebnem Pirildar, Levent Can |
| 21 |
[GO] |
2020―Jul―09 |
Misinterpreting data in lipidology in the era of COVID-19 |
Federica Fogacci, Claudio Borghi, Arrigo F.G. Cicero |
| 22 |
[GO] |
2020―Jul―09 |
Authors’ response to letter by Fogacci, Borghi and Cicero, “Misinterpreting data in lipidology in the era of COVID-19” |
Xiaoling Cao, Hui Wang, Wenbin Tan |
| 23 |
[GO] |
2020―Jun―23 |
Are Statins Safe in Patients With COVID-19? |
Dean G. Karalis |
| 24 |
[GO] |
2020―Jun―15 |
Prevention of endothelial dysfunction and thrombotic events in COVID-19 patients with familial hypercholesterolemia |
Alpo Vuorio, Petri T. Kovanen |
| 25 |
[GO] |
2020―Apr―30 |
Hypolipidemia is associated with the severity of COVID-19 |
Xiuqi Wei, Wenjuan Zeng, Jingyu Su, Huimin Wan, Xinqin Yu, Xiaoling Cao, Wenbin Tan, Hui Wang |
| 26 |
[GO] |
2020―Apr―13 |
From the editor: Confronting a pandemic or two |
John R. Guyton |
